Trial Highlights

Elamipretide is an investigational drug with the potential to modify disease through its apparent ability to restore normal energy production in damaged mitochondria, while decreasing oxidative stress.8 This clinical candidate is being developed for both rare and common diseases, representing a novel therapeutic approach with the potential to treat a wide variety of unmet patient needs.

In preclinical studies, the ophthalmic delivery of elamipretide has demonstrated the potential to be the first investigational topical ophthalmic formulation to treat both corneal and retinal diseases, offering a pragmatic alternative to treatments that require physician-administered ocular injections. 1,10,14,23,29

Ophthalmic Formulation of Elamipretide in Clinical Studies


Completed Clinical Trials

Elamipretide in Clinical Trials

For more information, visit www.clinicaltrials.gov and search ‘Stealth BioTherapeutics’.